351 related articles for article (PubMed ID: 34054808)
1. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.
Hsieh MH; Beirag N; Murugaiah V; Chou YC; Kuo WS; Kao HF; Madan T; Kishore U; Wang JY
Front Immunol; 2021; 12():641360. PubMed ID: 34054808
[TBL] [Abstract][Full Text] [Related]
2. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
Front Immunol; 2022; 13():960733. PubMed ID: 35967323
[TBL] [Abstract][Full Text] [Related]
3. A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
Madan T; Biswas B; Varghese PM; Subedi R; Pandit H; Idicula-Thomas S; Kundu I; Rooge S; Agarwal R; Tripathi DM; Kaur S; Gupta E; Gupta SK; Kishore U
Am J Respir Cell Mol Biol; 2021 Jul; 65(1):41-53. PubMed ID: 33784482
[TBL] [Abstract][Full Text] [Related]
4. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
5. Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D.
Al-Ahdal MN; Murugaiah V; Varghese PM; Abozaid SM; Saba I; Al-Qahtani AA; Pathan AA; Kouser L; Nal B; Kishore U
Front Immunol; 2018; 9():1586. PubMed ID: 30105014
[TBL] [Abstract][Full Text] [Related]
6. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.
Xu C; Wang A; Geng K; Honnen W; Wang X; Bruiners N; Singh S; Ferrara F; D'Angelo S; Bradbury ARM; Gennaro ML; Liu D; Pinter A; Chang TL
Viruses; 2021 May; 13(6):. PubMed ID: 34064066
[TBL] [Abstract][Full Text] [Related]
7. Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2.
Arroyo R; Grant SN; Colombo M; Salvioni L; Corsi F; Truffi M; Ottolina D; Hurst B; Salzberg M; Prosperi D; Kingma PS
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439781
[TBL] [Abstract][Full Text] [Related]
8. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
[TBL] [Abstract][Full Text] [Related]
9. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
[TBL] [Abstract][Full Text] [Related]
10. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
[TBL] [Abstract][Full Text] [Related]
11. An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2.
Tada T; Fan C; Chen JS; Kaur R; Stapleford KA; Gristick H; Dcosta BM; Wilen CB; Nimigean CM; Landau NR
Cell Rep; 2020 Dec; 33(12):108528. PubMed ID: 33326798
[TBL] [Abstract][Full Text] [Related]
12. Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis.
Hou Y; Ge S; Li X; Wang C; He H; He L
Chem Biol Interact; 2021 Apr; 338():109420. PubMed ID: 33609497
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
Edwards MJ; Becker KA; Gripp B; Hoffmann M; Keitsch S; Wilker B; Soddemann M; Gulbins A; Carpinteiro E; Patel SH; Wilson GC; Pöhlmann S; Walter S; Fassbender K; Ahmad SA; Carpinteiro A; Gulbins E
J Biol Chem; 2020 Nov; 295(45):15174-15182. PubMed ID: 32917722
[TBL] [Abstract][Full Text] [Related]
14. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
15. Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication.
Artman C; Brumfield KD; Khanna S; Goepp J
PLoS One; 2021; 16(5):e0252399. PubMed ID: 34048457
[TBL] [Abstract][Full Text] [Related]
16. Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions.
Goc A; Sumera W; Rath M; Niedzwiecki A
PLoS One; 2021; 16(6):e0253489. PubMed ID: 34138966
[TBL] [Abstract][Full Text] [Related]
17. Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model.
Jacob IB; Gemmiti A; Xiong W; Reynolds E; Nicholas B; Thangamani S; Jia H; Wang G
Front Immunol; 2024; 15():1370511. PubMed ID: 38596675
[TBL] [Abstract][Full Text] [Related]
18. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
19. Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells.
Dilawari R; Chaubey GK; Modanwal R; Dhiman A; Talukdar S; Kumar A; Raje CI; Raje M
J Innate Immun; 2024; 16(1):133-142. PubMed ID: 38325356
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis.
Bayati A; Kumar R; Francis V; McPherson PS
J Biol Chem; 2021; 296():100306. PubMed ID: 33476648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
